P&S Intelligence

Valued at $192.0 billion in 2018, the global complementary and alternative medicines market is predicted to reach a value of $271.8 billion in 2024, progressing at a CAGR of 6.0% from 2019 to 2024.

The global diagnostic imaging systems market revenue stood at $38.9 billion in 2019, and it is predicted to grow to $70.0 billion by 2030.

From $3.7 billion in 2015, the global peripheral I.V. catheter market is expected to grow to $5.5 billion by 2022, registering a 6.0% CAGR during the forecast period (2016–2022).

MEA Energy-Based Aesthetic Devices Market To Witness 7.1% CAGR during 2020–2030

The global dermacosmetics market reached a revenue of $57.0 billion in 2020 and it is predicted to attain a value of $115.2 billion by 2030.

Moreover, the surging prevalence of diabetes will propel the Hong Kong wound dressing market at a CAGR of 6.0% during the forecast period (2021–2030).

The U.S. beauty devices market reached a value of $17,623.1 million in 2020, and it is predicted to progress at a CAGR of 19.6% from 2021 to 2030 (forecast period).

The global x-ray imaging market revenue stood at $8,897.3 million in 2015, and it is predicted to grow to $12.4 billion by 2022.

According to P&S Intelligence, the market was valued at $872.0 million in 2018, and it is expected to generate $1,612.2 million revenue by 2024.

The surging prevalence of prostate cancer, mounting geriatric population, and soaring number of government initiatives are expected to drive the U.S. prostate cancer treatment devices market at a CAGR of 5.6% during the forecast period (2020–2030).